/ Nzalut
/ Nzalut


  • Composition :


  • Packaging Sizes/Strengths :

    40 mg Capsules & 160 mg Tablets

  • Use :

    Management of Metastatic Prostate Cancer

  • Prescription/Non Prescription :


  • Form :

    Tablet and Capsule

Product Description

is a nonsteroidal antiandrogen (NSAA) medication which is used in the treatment of prostate cancer. It is indicated for use in conjunction with castration in the treatment of metastatic castration-resistant prostate cancer (mCRPC), nonmetastatic castration-resistant prostate cancer, and metastatic castration-sensitive prostate cancer (mCSPC). It is taken by mouth. Enzalutamide was first described in 2006, and was introduced for the treatment of prostate cancer in 2012. It was the first second-generation NSAA to be introduced. It is on the World Health Organization’s List of Essential Medicines.

To buy or for more details